Neoadjuvant Study With Chemotherapy, Lapatinib And Trastuzumab In Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Neoplasms, Breast
Interventions: DRUG: lapatinib|BIOLOGICAL: trastuzumab|DRUG: paclitaxel|DRUG: fluorouracil|DRUG: epidoxorubicin|DRUG: cyclophosphamide
Sponsor: GlaxoSmithKline